Delivery Order SPE2DB20D3103-SPE2DB25FP1C4
Award Date
6/10/25
Potential Completion Date
6/11/25
Potential Value
$1.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $4,087.94, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Imatinib Mesylate 100 mg tablets, a medication used to treat certain types of cancer. The contract is a Firm Fixed Price Delivery Order with a completion date of January 6, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the...
This federal contract award, with ID SPE2DX15D1053|SPE2DX24F6JDQ, is for the delivery of 4,563,971,891 units of Imatinib Mesylate 400 mg tablets in packages of 30. The contract has a firm fixed price of $1,416.39 and an ultimate completion date of March 15, 2024. The award was made on March 14, 2024 to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. doing business as Amerisourcebergen. The contract was awarded by the Defense Logistics Agency...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,141.83 firm fixed-price delivery order is for the supply of 4,559,069,294 units of Imatinib Mesylate 400mg tablets. The award has an ultimate completion date of November 14, 2022 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,242.05 Firm Fixed Price Delivery Order is for the supply of 4,558,265,473 units of Imatinib Mesylate 100 mg tablets. The contract has an ultimate completion date of August 30, 2022. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
The Defense Logistics Agency awarded a $499 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 400mg Imatinib Mesylate tablets. As the prime contractor, Amerisourcebergen will deliver 30 tablets to a facility in Conshohocken, Pennsylvania, fulfilling the agency's requirements under the contract which runs from July 25 to July 26, 2023. The Defense Logistics Agency leverages strategic sourcing vehicles to procure pharmaceuticals and medical supplies in support of its...
This delivery order for $242 from the Defense Logistics Agency to Amerisourcebergen Drug Corp is for 400 mg tablets of Imatinib Mesylate. The order is for 30 tablets and is a firm fixed price contract with performance in Conshohocken, Pennsylvania. The completion date is October 20, 2023. No set-aside designation was used for this order, which is associated with the Defense Logistics Agency's mission to provide logistics support for the Department of Defense and foreign military partners.
This delivery order from the Defense Logistics Agency awards Amerisourcebergen Drug Corporation $599 for 400 mg tablets of Imatinib Mesylate. The firm fixed price order is for 30 tablets and requires delivery by October 20, 2023. The place of performance is Conshohocken, Pennsylvania. No set-aside designation was used for this order placed under an existing vehicle by the DLA to procure pharmaceutical products in support of its mission to provide logistics support to the U.S. military and...
Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $62,110 firm fixed price delivery order by the Defense Logistics Agency Troop Support Medical to provide 100 mg tablets of imatinib mesylate in 90-count bottles. Performance will take place in Conshohocken, Pennsylvania under contract number 4561970085. The contract is funded by the Defense Logistics Agency Troop Support Medical to support its medical supply needs. No subcontractors or set aside...
This federal contract award, identified as SPE2DB20D2200|SPE2DB25FW08V, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Gleevec 400 mg tablets, a medication used to treat certain types of cancer. The award has a ceiling value of $7,748.60 and is a firm fixed-price delivery order contract, with a completion date of December 6, 2024. This contract is not...
The Defense Logistics Agency Troop Support Medical awarded a $113,330 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 30 tablets of 400mg Imatinib Mesylate to be delivered to their Conshohocken, Pennsylvania facility by August 21, 2023. Amerisourcebergen will provide the requested pharmaceutical product to the Defense Logistics Agency under this contract with performance at their corporate headquarters. No subcontractors or set aside designations were identified. The...